Showing 1,841 - 1,860 results of 226,311 for search '(( 10 ((nn decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (a decrease)) ))', query time: 2.44s Refine Results
  1. 1841
  2. 1842
  3. 1843
  4. 1844
  5. 1845
  6. 1846

    MVEC microvessel formation is restricted in hydrogels exhibiting increased stiffness or decreased concentration of adhesive peptides. by Rebecca A. Scott (488956)

    Published 2020
    “…An unpaired student’s t-test detect statistical significance, *p<0.05 for 7.5 wt% hydrogels containing 3 mM RGD relative to either (<b>A, C-F</b>) 15wt% hydrogels containing 3 mM RGD or (<b>G, I-L</b>) 7.5wt% hydrogels containing 1 mM RGD.…”
  7. 1847
  8. 1848
  9. 1849

    Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

    Published 2015
    “…Cell density was measured with trypan blue hemocytometry to produce a growth curve over 96 hours. <b>(A)</b> Proliferation of VM-M3 cells was inhibited with decreasing glucose concentration and the addition of HBOT. …”
  10. 1850
  11. 1851
  12. 1852

    Inhibition of SHP-2 activity decreases <i>C</i>. <i>parvum</i> infectivity. by Eunice A. Varughese (824701)

    Published 2015
    “…<p>A) Dose-dependent decrease of Infections per field of view (y-axis) after treatment of FHs 74 Int cells with increasing concentrations of the SHP-2-specific inhibitor, SHP-2 PTPase Inhibitor. …”
  13. 1853

    Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro. by David A. Davis (239142)

    Published 2009
    “…Curves represent mean change in optical density (OD) at 30-s intervals. (E) Capzb2 decreases the rate and the extent of tubulin polymerization in a concentration-dependent manner. …”
  14. 1854
  15. 1855
  16. 1856

    Combination metabolic therapy decreases VM-M3 cell viability <i>in vitro</i>. by A. M. Poff (752552)

    Published 2015
    “…<b>(A-B)</b> βHB, LG, and LG+βHB+HBOT treatment decreased viability compared to control and HBOT treated cells. …”
  17. 1857
  18. 1858

    FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

    Published 2013
    “…<b>B)</b> Rho activity was measured using a Rhotekin binding assay at 70% confluence. The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”
  19. 1859
  20. 1860